Prop 65 Andro Settlements Include “Corrective Advertising” Provision
This article was originally published in The Tan Sheet
Executive Summary
Settling defendants in California's Prop 65 litigation against androstenedione supplement marketers would pay from $1,341 to $4,546 each to fund "corrective advertising" programs, according to proposed consent judgments filed in Oakland state court
You may also be interested in...
Prop 65 Steroid Suit Planned Against Supplements Named In Post
The Center for Environmental Health plans to file a Prop 65 suit in January against 19 dietary supplement manufacturers and retailers for selling products containing anabolic steroids without warning labels, the group announces in a recent notice letter
Prop 65 andro litigation
Weider, MuscleTech, M.D. Labs, SportPharma reach settlements with state of California in ongoing Prop 65 case against androstenedione supplement marketers. Agreements, which include payments for "corrective advertising" programs, penalties and warnings, are similar to consent judgments approved in Oakland state court June 28 (1"The Tan Sheet" June 10, 2002, p. 12). Case management conference with remaining defendants, including Bodyonics, slated for Aug. 2; Judge Ronald Sabraw is considering holding mini-trial on whether andro is anabolic steroid...
Met-Rx, AST To Place Warnings On "Andro" Products Under FTC Settlement
Sports supplement marketers Met-Rx USA and AST Sports Science agree in individual settlements with the Federal Trade Commission to place warnings on their androstenedione ("andro") supplements as well as an additional warning on andro supplements also containing ephedra.